n-iodosuccinimide has been researched along with n-succinimidyl 3-(trimethylstannyl)benzoate in 1 studies
| Studies (n-iodosuccinimide) | Trials (n-iodosuccinimide) | Recent Studies (post-2010) (n-iodosuccinimide) | Studies (n-succinimidyl 3-(trimethylstannyl)benzoate) | Trials (n-succinimidyl 3-(trimethylstannyl)benzoate) | Recent Studies (post-2010) (n-succinimidyl 3-(trimethylstannyl)benzoate) |
|---|---|---|---|---|---|
| 60 | 0 | 38 | 10 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, H; Bäck, T; Jacobsson, L; Karlsson, B; Lindegren, S; Skarnemark, G | 1 |
1 other study(ies) available for n-iodosuccinimide and n-succinimidyl 3-(trimethylstannyl)benzoate
| Article | Year |
|---|---|
High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate.
Topics: Antibodies, Monoclonal; Astatine; Benzoates; Colorectal Neoplasms; Humans; Radionuclide Imaging; Succinimides; Trimethyltin Compounds; Tumor Cells, Cultured | 2001 |